A Phase II Study of Alimta as First Line Chemotherapy for Advanced or Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2009
At a glance
- Drugs Pemetrexed (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 09 Jun 2009 Actual patient number (37) added as reported by ClinicalTrials.gov.
- 11 Jan 2008 Status change from in progress to completed according to ClinicalTrials.gov.
- 27 Dec 2007 Status changed from recruiting to in progress according to ClinicalTrials.gov.